Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


23.10.2017

2 Am J Surg
5 Ann Oncol
4 Ann Surg
6 Anticancer Res
1 BMC Cancer
1 Cancer
1 Cancer Lett
5 Dis Colon Rectum
1 Gastrointest Endosc
1 Hum Pathol
3 Int J Cancer
3 Int J Colorectal Dis
3 Int J Oncol
1 J Nucl Med
1 J Pathol
1 N Engl J Med
3 Oncogene
6 Oncol Rep
9 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg

  1. TUNG WY, Lin AY
    Disparities in incidence of early- and late-onset colorectal cancer between Hispanics and Whites: A 10-year SEER database study.
    Am J Surg. 2017 Oct 6. pii: S0002-9610(17)31368.
    PubMed     Text format    

  2. CULL F, Gray S, Johnstone M, Gillespie M, et al
    RE: "Significant elevation of carcinoembryonic antigen levels in abdominal drains after colorectal surgery may indicate early anastomotic dehiscence" - Berkovich et al.
    Am J Surg. 2017;213:1190-1191.
    PubMed     Text format    


    Ann Oncol

  3. APARICIO T, Bouche O, Taieb J, Maillard E, et al
    Bevacizumab + chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial - PRODIGE 20 study results.
    Ann Oncol. 2017 Sep 28. doi: 10.1093.
    PubMed     Text format     Abstract available

  4. TARAZONA N, Cervantes A
    Liquid biopsy: another tool towards tailored therapy in colorectal cancer.
    Ann Oncol. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format    

  5. BERGER MD, Stintzing S, Heinemann V, Yang D, et al
    Impact of genetic variations in the MAPK signaling pathway on outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: data from FIRE-3 and TRIBE trials.
    Ann Oncol. 2017 Aug 2. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. SANZ-GARCIA E, Argiles G, Elez E, Tabernero J, et al
    BRAF mutant Colorectal Cancer: prognosis, treatment and new perspectives.
    Ann Oncol. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. CREMOLINI C, Morano F, Moretto R, Berenato R, et al
    Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.
    Ann Oncol. 2017 Sep 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg

  8. VELLINGA TT, Kranenburg O, Frenkel N, Ubink I, et al
    Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
    Ann Surg. 2017;266:765-771.
    PubMed     Text format     Abstract available

  9. BORSTLAP WAA, Westerduin E, Aukema TS, Bemelman WA, et al
    Anastomotic Leakage and Chronic Presacral Sinus Formation After Low Anterior Resection: Results From a Large Cross-sectional Study.
    Ann Surg. 2017;266:870-877.
    PubMed     Text format     Abstract available

  10. LINECKER M, Bjornsson B, Stavrou GA, Oldhafer KJ, et al
    Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.
    Ann Surg. 2017;266:779-786.
    PubMed     Text format     Abstract available

  11. MAGGIORI L, Rullier E, Lefevre JH, Regimbeau JM, et al
    Does a Combination of Laparoscopic Approach and Full Fast Track Multimodal Management Decrease Postoperative Morbidity?: A Multicenter Randomized Controlled Trial.
    Ann Surg. 2017;266:729-737.
    PubMed     Text format     Abstract available


    Anticancer Res

  12. IKEMURA M, Hashida T
    Effect of Hyperglycemia on Antitumor Activity and Survival in Tumor-bearing Mice Receiving Oxaliplatin and Fluorouracil.
    Anticancer Res. 2017;37:5463-5468.
    PubMed     Text format     Abstract available

  13. SUNG JY, Na K, Kim HS
    Down-regulation of Inositol Polyphosphate 4-Phosphatase Type II Expression in Colorectal Carcinoma.
    Anticancer Res. 2017;37:5525-5531.
    PubMed     Text format     Abstract available

  14. TOKUNAGA T, Nishi M, Higashijima J, Yoshikawa K, et al
    Feasibility of Transanal Local Excision Following Chemoradiation for Lower Rectal Cancer.
    Anticancer Res. 2017;37:5617-5622.
    PubMed     Text format     Abstract available

  15. KAWAHARA H, Akiba T, Yanaga K
    Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases.
    Anticancer Res. 2017;37:5767-5769.
    PubMed     Text format     Abstract available

  16. IDE S, Toiyama Y, Okugawa Y, Oki S, et al
    Clinical Significance of C-Reactive Protein-to-Albumin Ratio with Rectal Cancer Patient Undergoing Chemoradiotherapy Followed by Surgery.
    Anticancer Res. 2017;37:5797-5804.
    PubMed     Text format     Abstract available

  17. TANASE T, Hamada C, Yoshino T, Ohtsu A, et al
    A Proposal for Progression-Free Survival Assessment in Patients with Early Progressive Cancer.
    Anticancer Res. 2017;37:5851-5855.
    PubMed     Text format     Abstract available


    BMC Cancer

  18. UNGARI AQ, Pereira LRL, Nunes AA, Peria FM, et al
    Cost-effectiveness analysis of XELOX versus XELOX plus bevacizumab for metastatic colorectal cancer in a public hospital school.
    BMC Cancer. 2017;17:691.
    PubMed     Text format     Abstract available


    Cancer

  19. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed     Text format    


    Cancer Lett

  20. ZHUGE W, Chen R, Vladimir K, Dong X, et al
    Costunolide specifically binds and inhibits thioredoxin reductase 1 to induce apoptosis in colon cancer.
    Cancer Lett. 2017 Oct 13. pii: S0304-3835(17)30630.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  21. SOURROUILLE I, Lefevre JH, Shields C, Colas C, et al
    Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman Score Be Modified?
    Dis Colon Rectum. 2017;60:1137-1146.
    PubMed     Text format     Abstract available

  22. JUSTINIANO CF, Xu Z, Becerra AZ, Aquina CT, et al
    Long-term Deleterious Impact of Surgeon Care Fragmentation After Colorectal Surgery on Survival: Continuity of Care Continues to Count.
    Dis Colon Rectum. 2017;60:1147-1154.
    PubMed     Text format     Abstract available

  23. HIDA K, Okamura R, Park SY, Nishigori T, et al
    A New Prediction Model for Local Recurrence After Curative Rectal Cancer Surgery: Development and Validation as an Asian Collaborative Study.
    Dis Colon Rectum. 2017;60:1168-1174.
    PubMed     Text format     Abstract available

  24. ZENG WG, Liu MJ, Zhou ZX, Wang ZJ, et al
    A Distal Resection Margin of </=1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
    Dis Colon Rectum. 2017;60:1175-1183.
    PubMed     Text format     Abstract available

  25. POMERRI F, Crimi F, Veronese N, Perin A, et al
    Prediction of N0 Irradiated Rectal Cancer Comparing MRI Before and After Preoperative Chemoradiotherapy.
    Dis Colon Rectum. 2017;60:1184-1191.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  26. CASSANI LS, Lanke G, Chen HC, Wang X, et al
    Comparison of nonampullary duodenal adenomas in patients with familial adenomatous polyposis versus patients with sporadic adenomas.
    Gastrointest Endosc. 2017;85:803-812.
    PubMed     Text format     Abstract available


    Hum Pathol

  27. GIANNICO GA, Gown AM, Epstein JI, Revetta F, et al
    Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract.
    Hum Pathol. 2017;67:152-159.
    PubMed     Text format     Abstract available


    Int J Cancer

  28. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    PubMed     Text format     Abstract available

  29. NIELL N, Larriba MJ, Ferrer-Mayorga G, Sanchez-Perez I, et al
    The human PKP2/Plakophilin-2 gene is induced by Wnt/beta-catenin in normal and colon cancer-associated fibroblasts.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31104.
    PubMed     Text format     Abstract available

  30. HOLCH JW, Ricard I, Stintzing S, Fischer von Weikersthal L, et al
    Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31114.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  31. MANFREDI S, Jooste V, Gay C, Faivre J, et al
    Time trends in colorectal cancer early postoperative mortality. A French 25-year population-based study.
    Int J Colorectal Dis. 2017 Oct 19. doi: 10.1007/s00384-017-2918.
    PubMed     Text format     Abstract available

  32. ZURLENI T, Cassiano A, Gjoni E, Ballabio A, et al
    Surgical and oncological outcomes after complete mesocolic excision in right-sided colon cancer compared with conventional surgery: a retrospective, single-institution study.
    Int J Colorectal Dis. 2017 Oct 16. doi: 10.1007/s00384-017-2917.
    PubMed     Text format     Abstract available

  33. HUNG HY, Chen JS, Chien-YuhYeh, Tang R, et al
    Preoperative alkaline phosphatase elevation was associated with poor survival in colorectal cancer patients.
    Int J Colorectal Dis. 2017 Oct 13. doi: 10.1007/s00384-017-2907.
    PubMed     Text format     Abstract available


    Int J Oncol

  34. JIANG D, Li J, Li J, Wang M, et al
    Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells.
    Int J Oncol. 2017 Oct 2. doi: 10.3892/ijo.2017.4143.
    PubMed     Text format     Abstract available

  35. TEO WH, Chen HP, Huang JC, Chan YJ, et al
    Human cytomegalovirus infection enhances cell proliferation, migration and upregulation of EMT markers in colorectal cancer-derived stem cell-like cells.
    Int J Oncol. 2017 Sep 25. doi: 10.3892/ijo.2017.4135.
    PubMed     Text format     Abstract available

  36. LIU K, Li J, Wu X, Chen M, et al
    GSK-3beta inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Int J Oncol. 2017 Oct 16. doi: 10.3892/ijo.2017.4163.
    PubMed     Text format     Abstract available


    J Nucl Med

  37. GRKOVSKI M, Emmas SA, Carlin SD
    18F-Fluoromisonidazole Kinetic Modeling for Characterization of Tumor Perfusion and Hypoxia in Response to Antiangiogenic Therapy.
    J Nucl Med. 2017;58:1567-1573.
    PubMed     Text format     Abstract available


    J Pathol

  38. IRSHAD S, Bansal M, Guarnieri P, Davis H, et al
    Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    J Pathol. 2017;242:178-192.
    PubMed     Text format     Abstract available


    N Engl J Med

  39. LEMERY S, Keegan P, Pazdur R
    First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
    N Engl J Med. 2017;377:1409-1412.
    PubMed     Text format    


    Oncogene

  40. BENTHANI FA, Herrmann D, Tran PN, Pangon L, et al
    'MCC' protein interacts with E-cadherin and beta-catenin strengthening cell-cell adhesion of HCT116 colon cancer cells.
    Oncogene. 2017 Oct 16. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

  41. WANG X, Haring MF, Rathjen T, Lockhart SM, et al
    Insulin resistance in vascular endothelial cells promotes intestinal tumour formation.
    Oncogene. 2017;36:4987-4996.
    PubMed     Text format     Abstract available

  42. HANLEY MP, Hahn MA, Li AX, Wu X, et al
    Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.
    Oncogene. 2017;36:5035-5044.
    PubMed     Text format     Abstract available


    Oncol Rep

  43. TIAN XQ, Guo FF, Sun DF, Wang YC, et al
    Downregulation of ZNF278 arrests the cell cycle and decreases the proliferation of colorectal cancer cells via inhibition of the ERK/MAPK pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6031.
    PubMed     Text format     Abstract available

  44. HE PY, Yip WK, Chai BL, Chai BY, et al
    Inhibition of cell migration and invasion by miR29a3p in a colorectal cancer cell line through suppression of CDC42BPA mRNA expression.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6037.
    PubMed     Text format     Abstract available

  45. QUE K, Tong Y, Que G, Li L, et al
    Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6041.
    PubMed     Text format     Abstract available

  46. ZHANG Y, Guo Y, Wang M, Dong H, et al
    Quercetrin from Toona sinensis leaves induces cell cycle arrest and apoptosis via enhancement of oxidative stress in human colorectal cancer SW620 cells.
    Oncol Rep. 2017 Oct 17. doi: 10.3892/or.2017.6042.
    PubMed     Text format     Abstract available

  47. LIU X, Wang Y, Zhao J
    MicroRNA337 inhibits colorectal cancer progression by directly targeting KRAS and suppressing the AKT and ERK pathways.
    Oncol Rep. 2017 Sep 25. doi: 10.3892/or.2017.5997.
    PubMed     Text format     Abstract available

  48. LI K, Na K, Sang T, Wu K, et al
    The ethanol extracts of sporoderm-broken spores of Ganoderma lucidum inhibit colorectal cancer in vitro and in vivo.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6010.
    PubMed     Text format     Abstract available


    PLoS One

  49. GORFINE M, Berndt SI, Chang-Claude J, Hoffmeister M, et al
    Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome.
    PLoS One. 2017;12:e0181269.
    PubMed     Text format     Abstract available

  50. YOKOYAMA S, Takeuchi A, Yamaguchi S, Mitani Y, et al
    Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    PLoS One. 2017;12:e0183337.
    PubMed     Text format     Abstract available

  51. OLSSON PO, Kalamajski S, Maccarana M, Oldberg A, et al
    Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.
    PLoS One. 2017;12:e0182973.
    PubMed     Text format     Abstract available

  52. KUMARASAMY V, Kuppusamy UR, Jayalakshmi P, Samudi C, et al
    Exacerbation of colon carcinogenesis by Blastocystis sp.
    PLoS One. 2017;12:e0183097.
    PubMed     Text format     Abstract available

  53. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    PubMed     Text format     Abstract available

  54. KAWAKUBO M, Demehri S, Manstein D
    Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
    PLoS One. 2017;12:e0184852.
    PubMed     Text format     Abstract available

  55. DARLING NJ, Balmanno K, Cook SJ
    ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.
    PLoS One. 2017;12:e0184907.
    PubMed     Text format     Abstract available

  56. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Text format     Abstract available

  57. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: